Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 1026706 in Postoperative Dental Pain
NCT02084511Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of BI 1026706 in odontalgia (4 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Sum of Pain Intensity Difference 0-8 hours. Started Mar 2014; status: completed.
02
Drugs
BI 1026706
03
Conditions
odontalgia
Beyond the preview
Go deeper on NCT02084511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02084511.